Food News and Research

RSS

FDA approves RLI’s Absorica to treat severe recalcitrant nodular acne

Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, a novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.

30 May 2012

Partnership between Molecular Profiles and GEA Process Engineering to demonstrate benefits of new technology

Molecular Profiles, a leading specialist contract research and manufacturing organisation, announces that it has entered into a strategic collaboration with GEA Process Engineering - the company behind the world-recognized GEA Niro spray drying technology.

29 May 2012

FDA accepts NDA filing for KYNAMRO to treat HoFH

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced today that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for KYNAMRO (mipomersen sodium) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).

29 May 2012

Safety of breast implants

Following the recent scandal, described in May 2012 by the BBC as the “PIP breast implant scandal”, (1) many women may have been put off having breast implants. But how safe exactly is breast enlargement? And how do the different methods compare?

29 May 2012

Pre-harvest vaccines for management of E. coli in Canadian beef receive favourable conclusion

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a Public Health Agency of Canada study assessing the effects of various interventions on the management of E. coli O157:H7 in Canadian beef came to a favourable conclusion with regard to pre-harvest vaccines such as the Company's Econiche cattle vaccine.

29 May 2012

Spectrum initiates enrollment in RenaZorb Phase 1 trial in healthy volunteers

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.

29 May 2012

Mediterranean diet associated with mental and physical health

The study has been published in the 'European Journal of Clinical Nutrition.' For years the Mediterranean diet has been associated with a lesser chance of illness and increased well-being. A new study has now linked it to mental and physical health too.

29 May 2012

Watson, Endo and Teikoku Seiyaku enter settlement agreement to resolve Lidoderm patent litigation

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an agreement with Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co., Ltd to settle all outstanding patent litigation related to Watson's generic version of Lidoderm.

29 May 2012

Simple changes in health behavior spur big and lasting results

Simply ejecting your rear from the couch means your hand will spend less time digging into a bag of chocolate chip cookies. That is the simple but profound finding of a new Northwestern Medicine study, which reports simply changing one bad habit has a domino effect on others. Knock down your sedentary leisure time and you'll reduce junk food and saturated fats because you're no longer glued to the TV and noshing. It's a two-for-one benefit because the behaviors are closely related.

29 May 2012

Sixty-fifth World Health Assembly covers some of the biggest challenges facing public health

The Sixty-fifth World Health Assembly concluded Saturday after adopting 21 resolutions and three decisions on a broad range of health issues. The six days of discussions involved nearly 3000 delegates, including health ministers and senior health officials from amongst the 194 WHO Member States, as well as representatives from civil society and other stakeholders.

28 May 2012

Covalon second quarter revenue increases to $1,090,038

Mr. Brian Pedlar, President and CEO of Covalon Technologies Ltd., an advanced medical technologies company, is pleased to provide the following update.

28 May 2012

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.

28 May 2012

UC Irvine immunologist to create new line of neural stem cells for MS

A UC Irvine immunologist will receive $4.8 million to create a new line of neural stem cells that can be used to treat multiple sclerosis.

28 May 2012

Results from Medtronic’s Resolute DES clinical study on CAD

According to study results to be featured in Sunday's late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute drug-eluting stent (DES) from Medtronic, Inc. yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow-up.

From Medtronic 28 May 2012

New, more accurate test for paralytic shellfish poisons

For decades, U.S. fisheries have tested the algal toxin levels of shellfish caught for human consumption by processing a sample of the shellfish in a blender and injecting the resulting slurry into the abdomen of live mice, causing them to suffer seizures, paralysis, and death by suffocation.

25 May 2012

U.N. official calls for more leadership, funding, comprehensive plan to address potential humanitarian crisis in Sahel

U.N. Under-Secretary-General for Humanitarian Affairs Valerie Amos on Thursday "called for strong leadership and a comprehensive response plan, as well as donor support, for the food crisis in West Africa's drought-prone Sahel region, warning that hunger could lead to a humanitarian catastrophe," the U.N. News Centre reports (5/24).

25 May 2012

G8 leaders must follow through on food security commitments

"I have just returned from a whirlwind visit to Washington, D.C., and Chicago, where I participated in a number of events around the G8 and NATO Summits focused on food and nutrition security," Tom Arnold, CEO of Concern Worldwide, writes in the Huffington Post's "Global Motherhood" blog, adding, "Among so many world leaders and high-level representatives from civil society and academia, I felt a sense of critical mass beginning to form in the fight to end global hunger."

25 May 2012

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Sihuan Pharmaceutical Holdings Group Ltd., a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China's prescription market, announced that Roxatidine Acetate Hydrochloride for Injection, Sihuan Pharmaceutical's first-to-market generic drug, recently passed on-site inspection for drug registration conducted by the Chinese State Food and Drug Administration.

25 May 2012

FDA reauthorization bill sails through Senate

Showing unusual bipartisan spirit, the Senate passed a massive FDA user-fee reauthorization bill Thursday designed to prevent drug shortages and speed federal approval of medicines, including lower-cost generic versions.

25 May 2012

$CDC report finds states spend only a fraction of tobacco funds to fight smoking$

CDC report finds states spend only a fraction of tobacco funds to fight smoking

The study says states collected $244 billion from tobacco settlement payments between 1998 and 2010, and used about $8 billion of that for anti-smoking campaigns.

25 May 2012